We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$337M
AUM Growth
-$8.73M
Cap. Flow
-$4.66M
Cap. Flow %
-1.38%
Top 10 Hldgs %
36.68%
Holding
216
New
7
Increased
44
Reduced
112
Closed
8

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$732K
2
ELV icon
Elevance Health
ELV
+$644K
3
ADBE icon
Adobe
ADBE
+$573K
4
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$510K
5
NKE icon
Nike
NKE
+$337K

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Healthcare 15.23%
3 Financials 13.1%
4 Industrials 8.56%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.1T
$26.1M 7.75%
57,622
-442
-0.8% -$204K
AAPL icon
2
Apple
AAPL
$4.44T
$18M 5.34%
71,861
-1,103
-2% -$260K
MSFT icon
3
Microsoft
MSFT
$3.42T
$17.6M 5.22%
41,694
-174
-0.4% -$74.1K
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.22T
$10.9M 3.24%
57,329
-1,915
-3% -$338K
VTEB icon
5
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$10.3M 3.06%
205,793
-12,330
-6% -$623K
VTIP icon
6
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$10.2M 3.02%
210,491
+1,134
+0.5% +$55.4K
VTI icon
7
Vanguard Morningstar Total Stock Market ETF
VTI
$656B
$8.59M 2.55%
29,636
+380
+1% +$111K
JNJ icon
8
Johnson & Johnson
JNJ
$611B
$8.42M 2.5%
58,216
+243
+0.4% +$37.7K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.23T
$7.04M 2.09%
37,166
-2,120
-5% -$371K
ABT icon
10
Abbott
ABT
$180B
$6.44M 1.91%
56,906
-1,111
-2% -$128K
AMZN icon
11
Amazon
AMZN
$2.9T
$5.46M 1.62%
24,899
-1,155
-4% -$236K
SYK icon
12
Stryker
SYK
$123B
$5.38M 1.6%
14,946
-232
-2% -$86K
ABBV icon
13
AbbVie
ABBV
$443B
$5.31M 1.58%
29,890
-552
-2% -$101K
SPY icon
14
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$4.76M 1.41%
8,129
-997
-11% -$587K
PEP icon
15
PepsiCo
PEP
$190B
$4.75M 1.41%
31,254
-713
-2% -$117K
BRK.A icon
16
Berkshire Hathaway Class A
BRK.A
$1.1T
$4.09M 1.21%
6
CSCO icon
17
Cisco
CSCO
$452B
$3.91M 1.16%
66,102
-4,528
-6% -$259K
MOAT icon
18
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$3.81M 1.13%
41,043
+2,563
+7% +$247K
WMT icon
19
Walmart Inc
WMT
$885B
$3.63M 1.08%
40,189
-1,960
-5% -$170K
NVDA icon
20
NVIDIA
NVDA
$4.77T
$3.59M 1.06%
26,715
-126
-0.5% -$17.4K
ANET icon
21
Arista Networks
ANET
$223B
$3.58M 1.06%
32,412
-1,088
-3% -$112K
CEF icon
22
Sprott Physical Gold and Silver Trust
CEF
$7.37B
$3.51M 1.04%
147,730
-1,236
-0.8% -$30.6K
ITW icon
23
Illinois Tool Works
ITW
$81.4B
$3.5M 1.04%
13,820
-40
-0.3% -$10.6K
RTX icon
24
RTX Corp
RTX
$286B
$3.24M 0.96%
27,957
-69
-0.2% -$8.34K
VPL icon
25
Vanguard FTSE Pacific ETF
VPL
$8.06B
$3.13M 0.93%
44,026
-1,072
-2% -$80.1K

Similar funds

Roberts, Glore & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Roberts, Glore & Co held 216 positions worth $337M, down 2.5% from $346M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Roberts, Glore & Co's Q4 2024 filing shows 7 new, 44 increased, 112 reduced and 8 closed positions. Its largest new stake was ASML: 1,020 shares worth $707K. The largest sale was CVS Health, an estimated $906K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q4 2024 buy was ASML: 1,020 shares worth $707K.
  • Roberts, Glore & Co added most to Elevance Health in Q4 2024, an estimated $644K increase.
  • Roberts, Glore & Co's biggest Q4 2024 reduction was CVS Health, cutting an estimated $906K.
  • Roberts, Glore & Co fully exited Estee Lauder in Q4 2024, selling an estimated $507K.
  • Roberts, Glore & Co's ten largest holdings make up 37% of its $337M portfolio in Q4 2024.
  • Roberts, Glore & Co opened 7 new positions and closed 8 in Q4 2024.
  • Roberts, Glore & Co's portfolio value fell 2.5% quarter-over-quarter to $337M.

Based on Roberts, Glore & Co's 13F filing for Q4 2024, filed 7 Feb 2025.